Completed OBSERVATIONAL NCT04393805

Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto (HETHICO)

Sponsor: Quovadis Associazione

Interventions Low Molecular Weight Heparin

Updated 7 times since 2020 Last updated: Mar 17, 2021 Started: Jun 1, 2020 Primary completion: Feb 26, 2021 Completion: Feb 26, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04393805, this observational or N/A phase trial focuses on COVID-19 and Hypercoagulability and remains completed. Sponsored by Quovadis Associazione, it has been updated 7 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Apr 2021 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Jan 2021 — Apr 2021 [monthly]

Recruiting

▶ Show 2 earlier versions

Oct 2020 — Jan 2021 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Jun 2020 — Oct 2020 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Quovadis Associazione
University of Padova

Data source: Quovadis Associazione

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Padua, Italy